I have two groups - patients (n=60) and healthy controls (n=20), M:F appr 1:1 for now, I have half of the patients already. The distribution is such because the type of analysis (MLPA) and the disease (AML) do not really necessitate a 1:1 for both groups, healthy control samples are mainly needed for quality measures of MLPA (3 controls are enough per run with